Potentially more than $850 million from the settlement would go directly to individual victims, making it different from the ...

Cellectar Biosciences, Inc. (Nasdaq: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and ...

Learn about sickle cell disease, a genetic blood disorder affecting millions in India, with potential treatments and ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The Animal Welfare Institute (AWI) applauds recent announcements by the National Institutes of Health and the US Food and ...

CSL Behring’s Andembry is now approved as a subcutaneous, self-injection for hereditary angioedema (HAE) patients ages 12 and older and will be available by the end of June 2025.

A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for ...

Responding to MAUDE data, some have safety concerns but others aren’t surprised to see more events in higher-risk patients.

Major food brand General Mills will remove all artificial dyes from its products by 2027, the company announced Tuesday. The company also announced plans to remove “certified colors” from all of its ...

While the previous PATHFINDER study—a prospective, year-long examination of about 6,600 people—showed that Galleri could more ...

More than 70 new laws take effect in Florida on July 1, 2025.